Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Serum Endocan, Alarin, and Galanin-Like Peptide Levels With Diabetic Retinopathy Stages and Optical Coherence Tomography (OCT) Findings

NCT07434362 is registered in ClinicalTrials.gov with Elazıg Fethi Sekin Sehir Hastanesi as lead sponsor.

NCT NCT07434362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07434362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Serum Endocan, Alarin, and Galanin-Like Peptide Levels With Diabetic Retinopathy Stages and Optical Coherence Tomography (OCT) Findings
Lead sponsor
Elazıg Fethi Sekin Sehir Hastanesi
Phase
Not applicable
Overall status
Completed
Start date
January 30, 2026
Completion date
February 18, 2026
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetic retinopathy, retinal microvascular disease